Clinical
RSSArticles
-
New treatment option for trichomoniasis?
-
Reach college students with information on EC
-
Postmenopausal Hormone Therapy and the Risk of Breast Cancer
-
Pharmacology Watch: GlaxoSmithKline Withdraws Lymerix: Company ‘Cuts Losses’ on Controversial Lyme Disease Vaccine
-
MORE Data, MORE Questions
-
Intraperitoneal Chemotherapy for Ovarian Carcinoma
-
Empiric Vaginal Metronidazole in the Management of the ASCUS Pap Smear
-
Endometriosis is the focus of new scientific research
Research has just provided a first step toward providing a more informed way of classifying endometriosis based on the underlying biological cause of the disease. Scientists might be able to develop a patient stratification system similar to that used for breast cancer patients, whose treatments are tailored to the molecular profile of their tumors. -
New treatment eyed for pain of vulvodynia
Results of a new study indicate that vulvodynia incidence varies by age, ethnicity, and marital status, with a potential higher risk for women with pre-existing depression, sleep, or pain disorders. -
CTU Update